Amanda Leach

GlaxoSmithKline (United Kingdom) ORCID: 0000-0002-4638-8392

1

h-index

1

Publications

134

Citations

Publications

1 shown

Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial

Kwaku Poku Asante , Salim Abdulla , Sélidji Todagbé Agnandji +39 more

2011 The Lancet Infectious Diseases 134 citations

Frequent Co-Authors

Kwaku Poku Asante

London School of Hygiene & Tropical Medicine

Salim Abdulla

Ifakara Health Institute

Sélidji Todagbé Agnandji

University of Tübingen

John Lyimo

Ifakara Health Institute

Johan Vekemans

AstraZeneca (United Kingdom)

Solange Soulanoudjingar

University of Tübingen

Researcher Info

h-index: 1
Publications: 1
Citations: 134
Institution: GlaxoSmithKline (United Kingdom)

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-4638-8392

Impact Metrics

h-index 1

h-index: Number of publications with at least h citations each.

Academic Output Over Time